Panthera leo
LEO Pharma’s Acquisition of Timber Pharmaceuticals’ Assets Faces Setback Due to Late-Stage Study Failure
LEO Pharma, Timber Pharmaceuticals, TMB-001, congenital ichthyosis, late-stage study failure, asset acquisition
Medical Devices Outshine Rx Drugs at Cannes Lions, Highlighting Shift in Customer Focus
Cannes Lions, Medical Devices, Rx Drugs, Customer Focus, Jury President